Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
First Advantage
FA
$2.83B
| $1.61M | ﹤0.01% |
100,100
| – | – |
|
1927
BrightView Holdings
BV
$1.34B
| $1.61M | ﹤0.01% |
120,700
+37,800
| +46% | +$503K |
|
1928
MiMedx Group
MDXG
$1.06B
| $1.6M | ﹤0.01% |
231,300
+2,400
| +1% | +$16.6K |
|
1929
Pitney Bowes
PBI
$1.97B
| $1.59M | ﹤0.01% |
312,200
| – | – |
|
|
PGRE
1930
Paramount Group
PGRE
$1.59B
| $1.58M | ﹤0.01% |
342,043
+20,900
| +7% | +$96.8K |
|
1931
Maravai LifeSciences
MRVI
$404M
| $1.58M | ﹤0.01% |
221,000
| – | – |
|
1932
Clearwater Paper
CLW
$351M
| $1.58M | ﹤0.01% |
32,600
-400
| -1% | -$19.4K |
|
1933
Metallus
MTUS
$710M
| $1.58M | ﹤0.01% |
77,800
+700
| +0.9% | +$14.2K |
|
1934
TechTarget
TTGT
$429M
| $1.57M | ﹤0.01% |
50,500
| – | – |
|
1935
Protolabs
PRLB
$1.2B
| $1.57M | ﹤0.01% |
50,900
| – | – |
|
1936
Southside Bancshares
SBSI
$927M
| $1.56M | ﹤0.01% |
56,618
| – | – |
|
1937
ProPetro Holding
PUMP
$506M
| $1.56M | ﹤0.01% |
179,900
+16,700
| +10% | +$145K |
|
|
PLYA
1938
DELISTED
Playa Hotels & Resorts
PLYA
| $1.56M | ﹤0.01% |
185,400
-5,900
| -3% | -$49.5K |
|
1939
Marcus & Millichap
MMI
$1.29B
| $1.55M | ﹤0.01% |
49,300
| – | – |
|
1940
Viasat
VSAT
$4.28B
| $1.55M | ﹤0.01% |
122,224
| – | – |
|
1941
XPEL
XPEL
$993M
| $1.55M | ﹤0.01% |
43,600
| – | – |
|
1942
Healthcare Services Group
HCSG
$1.2B
| $1.55M | ﹤0.01% |
146,163
| – | – |
|
1943
Clearway Energy Class A
CWEN.A
$3.21B
| $1.54M | ﹤0.01% |
68,150
+3,300
| +5% | +$74.8K |
|
1944
Koppers
KOP
$570M
| $1.54M | ﹤0.01% |
41,700
+500
| +1% | +$18.5K |
|
1945
Amneal Pharmaceuticals
AMRX
$3.17B
| $1.54M | ﹤0.01% |
242,100
| – | – |
|
1946
United Natural Foods
UNFI
$1.8B
| $1.54M | ﹤0.01% |
117,200
| – | – |
|
1947
Aurinia Pharmaceuticals
AUPH
$1.68B
| $1.53M | ﹤0.01% |
268,500
| – | – |
|
1948
Simulations Plus
SLP
$289M
| $1.53M | ﹤0.01% |
31,400
| – | – |
|
1949
Fiverr
FVRR
$878M
| $1.53M | ﹤0.01% |
65,105
+500
| +0.8% | +$11.7K |
|
1950
BioLife Solutions
BLFS
$1.28B
| $1.52M | ﹤0.01% |
71,100
| – | – |
|